Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Sarah A. Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, Giada Bianchi, Manisha Bhutani, Leslie A. Crews, Tom Cupedo, Hannah Giles, Sarah Gooding, Jens Hillengass, Lukas John, Shari Kaiser, Lydia Lee, Kylee Maclachlan, Marcelo C. Pasquini, Flavia Pichiorri, Nina Shah, Monica Shokeen, Brian R. Shy, Eric L. SmithRaluca Verona, Saad Z. Usmani, Philip L. McCarthy

Research output: Contribution to journalArticlepeer-review

Abstract

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.

Original languageEnglish (US)
Pages (from-to)446-454
Number of pages9
JournalTransplantation and Cellular Therapy
Volume28
Issue number8
DOIs
StatePublished - Aug 2022

Keywords

  • CAR T cell
  • Imaging
  • Multiple myeloma
  • Resistance
  • Tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Molecular Medicine
  • Hematology
  • Cell Biology
  • Transplantation

Fingerprint

Dive into the research topics of 'Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma'. Together they form a unique fingerprint.

Cite this